Phosphate Therapeutics

About:

Phosphate Therapeutics is focused on the development of mineral-derived hospital pharmaceuticals.

Website: http://www.phosphatetx.com

Top Investors: Inventages Venture Capital Investment Inc.

Description:

Phosphate Therapeutics, a UK-based independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals. The company intends to use the capital to complete the Phase 2 development of its phosphate binder (PT20) for the treatment of a late-stage renal disease suffer from systemic phosphate accumulation, hyperphosphataemia, whose global rights were acquired from the Medical Research Council.

Total Funding Amount:

10.5M EUR

Headquarters Location:

Manchester, Manchester, United Kingdom

Founded Date:

2011-01-01

Founders:

Christian Schweiger

Number of Employees:

1-10

Last Funding Date:

2012-03-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai